Screener
Altimmune ALT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $400.72M.
The source filing: Altimmune’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
FAQ
- What is Altimmune's market capitalization?
- Altimmune (ALT) reported market capitalization of $400.72M in Q1 2026.
- How has Altimmune's market capitalization changed year-over-year?
- Altimmune's market capitalization increased by 4.1% year-over-year, from $385.07M to $400.72M.
- What is the long-term trend for Altimmune's market capitalization?
- Over 5 years (2020 to 2025), Altimmune's market capitalization has grown at a -3.4% compound annual growth rate (CAGR), from $448.25M to $376.68M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Altimmune's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude